Ms Mitzi van Andel

Ms Mitzi van Andel

Amsterdam UMC - Location Academic Medical Center, Amsterdam (Netherlands (The))

Mitzi van Andel is currently working on her dissertation at Amsterdam UMC, University of Amsterdam, the Netherlands. She has a special interest in congenital cardiology, Marfan syndrome in particular. Her current work focuses on a new clinical trial investigating the effect of Resveratrol on aortic function in Marfan syndrome patients.

Presentations

Longitudinal changes in aortic distensibility in patients with Marfan syndrome

Event: ESC Congress 2021 - The Digital Experience

Topic: Imaging

Session: Diseases of the Aorta ePosters

Access

Abnormal aortic hemodynamics at predilection sites for dissection in patients with Marfan Syndrome: a 4D flow study

Event: EuroCMR 2021

Topic: Congenital Heart Disease

Session: ePoster session

Access

Effects of losartan and beta-blockers on aortic root dilatation in patients with Marfan Syndrome - results of the extended COMPARE trial

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Inherited diseases of the aorta: when science meets practice

Access

Plasma levels of microfibrillar associated protein type 4 (MFAP4) are predictive for aortic dissection in patients with Marfan Syndrome

Event: ESC Congress 2019

Topic: Aortic Dissection, Acute Intramural Haematoma

Session: Inherited diseases of the aorta: when science meets practice

Access

Ms Mitzi van Andel

Biography

Contributor content

Longitudinal changes in aortic distensibility in patients with Marfan syndrome

Abnormal aortic hemodynamics at predilection sites for dissection in patients with Marfan Syndrome: a 4D flow study

Effects of losartan and beta-blockers on aortic root dilatation in patients with Marfan Syndrome - results of the extended COMPARE trial

Plasma levels of microfibrillar associated protein type 4 (MFAP4) are predictive for aortic dissection in patients with Marfan Syndrome

ESC 365 is supported by